Loading organizations...

§ Private Profile · Greensboro, NC, USA
Ventricle Health is a technology company.
Ventricle Health operates a virtual cardiology platform, delivering comprehensive heart failure care within both clinical and home settings. The company leverages a national, value-based care network to provide non-invasive diagnostic capabilities and continuous management for heart failure patients. This approach integrates remote patient monitoring, health coaching, and virtual consultations to optimize patient outcomes and streamline care delivery.
The company was founded in 2021 by Dr. Daniel Bensimhon, a distinguished heart failure cardiologist. His insight stemmed from the critical need to address pervasive challenges in heart failure management, including limited access to specialized care, escalating costs, and variable patient outcomes. Dr. Bensimhon established Ventricle Health to overcome these hurdles through an accessible, technology-enabled care model.
Ventricle Health serves heart failure patients by bridging care gaps and offering convenient, high-quality cardiology services directly to their homes. The company’s vision is to stabilize patients within their home environments, improve clinical results, and enhance the overall patient experience by ensuring frictionless access to expert cardiology providers and advanced therapies. It aims to reshape how chronic cardiac conditions are managed.
Ventricle Health has raised $8.0M across 1 funding round.
Ventricle Health has raised $8.0M in total across 1 funding round.
Ventricle Health has raised $8.0M in total across 1 funding round.
Ventricle Health's investors include Anurag Kondapalli, Waterline Ventures.
Ventricle Health is a healthcare technology company founded in 2021 that provides a national, value-based cardiology provider network focused on digital cardiology services for heart failure and other cardiac conditions.[1][2][4] It offers a home-based care model, connecting patients to cardiologists, nurses, health coaches, and pharmacists via remote monitoring devices, personalized medication plans, and rapid access to guideline-directed medical therapy (GDMT), primarily serving heart failure patients to improve outcomes and reduce costs.[1][4] The company has raised $8M in seed VC funding about 8 months ago (as of mid-2025), operates from Greensboro, North Carolina, with under 25 employees, and demonstrates early growth momentum in the digital health space.[1][2]
Ventricle Health was founded in 2021 by Dr. Dan Bensimhon, a leading heart failure cardiologist, with the vision to create the most proactive, engaging, and impactful provider network for cardiac care in the U.S.[2][3] Based in Greensboro, North Carolina, the company emerged from Bensimhon's expertise to address gaps in heart failure management, leveraging digital tools for home-based care amid rising demand for remote cardiology solutions post-COVID.[1][4] Early traction includes securing $8M in seed funding roughly 8 months prior to late 2025, establishing a national network, and focusing on value-based care models evidenced by claims data showing improved GDMT initiation.[1][4]
Ventricle Health rides the digital health wave in cardiology, capitalizing on post-pandemic telehealth adoption, aging populations, and chronic disease burdens like heart failure, which drives high U.S. healthcare costs (e.g., 30-90 day readmission trends).[1][4] Timing aligns with value-based care shifts under Medicare and payer pressures for outcomes over volume, favoring remote monitoring amid shortages of in-person specialists.[4] Market forces include AI-enhanced longitudinal care (similar to peers like Vivid Health) and regulatory tailwinds like HITRUST/HIPAA compliance in cardiac rehab tech.[1] It influences the ecosystem by pioneering proactive networks, potentially lowering national readmission rates and enabling scalable GDMT, as supported by registry data.[4]
Ventricle Health is poised for expansion through additional funding rounds, geographic scaling, and tech integrations like AI for predictive monitoring, building on its $8M seed and clinical validations.[1][4] Trends like value-based reimbursement growth, wearable sensor proliferation, and hybrid care models will shape its path, amplifying impact in a $10B+ digital cardiology market.[1] Its influence may evolve from niche heart failure specialist to broader cardiac platform, redefining home-based care—echoing its founding vision of proactive networks that transform patient access and outcomes.[2][4]
Ventricle Health has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Seed in October 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2023 | $8M Seed | Anurag Kondapalli | Waterline Ventures | Announced |